NUDT1 and cancer: Also, we argue these MTH1 inhibitors are not to be confused with microtubule poisons, as they: (a) largely show distinct mitotic defects different from microtubule poisons, (b) effectively target microtubule‐resistant cancers (unpublished), (c) are highly tolerable and not toxic to nontransformed cells and (d) introduce oxidative DNA damage.